Last updated: August 13, 2025
Introduction
The World Intellectual Property Organization (WIPO) patent application WO2012142504 pertains to a biomedical invention, likely in the pharmaceutical domain, granted under the Patent Cooperation Treaty (PCT). This patent application embodies innovations in drug development, encompassing novel compounds, formulations, or therapeutic methods. An in-depth review of its scope, claims, and the broader patent landscape offers vital insights for stakeholders in pharmaceutical R&D, licensing, and competitive strategy.
This analysis systematically examines the scope and claims of WO2012142504, evaluates its novelty and inventive step, contextualizes it within the existing patent landscape, and discusses implications for market and R&D navigation.
Overview of WO2012142504
Published in September 2012 [1], WO2012142504 represents a filed patent application addressing specific drug-related inventions—likely focusing on novel chemical entities, their derivatives, or formulations with therapeutic relevance. Though the complete patent document must be examined for precise technical content, patent abstracts and claims typically encompass scope defining the invention's breadth encompassing chemical structures, uses, and formulations.
Note: Without access to the full text here, this analysis synthesizes typical considerations based on the WO number, patent topic areas, and public patent databases.
Scope of the Patent Application
The scope of WO2012142504 is primarily dictated by its claims—defining the legal boundaries of the invention—and by the detailed description justifying these claims.
Key Attributes of the Scope
-
Chemical Composition Claims: The patent likely covers a class of compounds, possibly derivatives of a known drug scaffold, with specific substituents or modifications conferring improved pharmacological profiles. For example, it might claim compounds with modifications that enhance bioavailability or selectivity.
-
Method of Use: The application potentially claims methods of treating particular diseases, diseases' specific stages, or employing the compounds for diagnostic purposes, broadening the scope beyond mere chemical entities.
-
Formulation and Delivery: Claims may encompass specific pharmaceutical formulations, such as sustained-release matrices, conjugates, or combinations with other therapeutic agents.
-
Manufacturing Processes: Innovations in synthesis or purification techniques could also be claimed, especially if they provide efficiency or stability advantages.
-
Systems and Devices: If relevant, claims might extend to delivery devices or diagnostic systems incorporating the compounds.
Scope Consideration: The scope extends to any compound variations and use methods falling within the explicit language of the claims, which generally include Markush structures and broad functional language to maximize protection.
Claims and Their Significance
Type and Hierarchy of Claims
-
Independent Claims: Usually claim the core chemical structures or primary methods of use, establishing the broadest protection.
-
Dependent Claims: Add specific limitations such as particular substitutions, preparation methods, or therapeutic centers, narrowing but strengthening the protection.
Analysis of Core Claims
While the exact claims are proprietary, based on typical pharmaceutical patents, the core claims likely cover:
-
Novel Chemical Entities: Specific compounds with optimized activity profiles.
-
Therapeutic Use Claims: Methods for treating conditions such as cancer, infections, or neurological disorders.
-
Formulations & Delivery: Novel formulations enhancing stability, release, or targeting.
The breadth and language of these claims determine market exclusivity and influence the capacity to block competitors.
Innovative Elements: Likely include unique substitutions or combinations not previously disclosed, contributing to inventive step over prior art.
Scope Evaluation
-
Breadth: Broad claims encompassing many analogs can deter competitors but risk invalidation if overly generic in view of prior art.
-
Specificity: Well-structured dependent claims fine-tune scope, shielding specific embodiments.
Claim Construction & Strength
Effective claim drafting ensures a balance—broad enough to cover competitive analogs and narrow enough to pass novelty and inventive step criteria. The scope should explicitly cover the inventive contribution, mitigating challenges.
Patent Landscape Analysis
Prior Art Context
The patent landscape surrounding WO2012142504 encompasses:
-
Pre-existing Patents: Prior art in the same chemical class or therapeutic area. Patent databases confirm whether similar compounds or methods have been disclosed, impacting novelty assessment.
-
Related Applications: Earlier WO or national phase patent applications in the same jurisdiction that may threaten patentability or provide territorial rights.
-
Competitive Patents: Other players with overlapping claims potentially leading to freedom-to-operate analysis.
Key Patent Families & Competitors
-
Major Players: Leading pharmaceutical companies or biotech firms active in the same therapeutic area might hold similar patents.
-
Patent Clusters: Identification of patent clusters with similar claims indicates crowded patent landscapes, impacting licensing or infringement risk.
-
Patent Expiry & Status: The lifespan and enforceability influence R&D investment decisions.
Legal & Strategic Positioning
-
Novelty & Inventive Step: The patent must demonstrate an inventive step over the prior art. This relies on detailed claim construction and patent prosecution history.
-
Freedom-to-Operate (FTO): Investors and licensees assess whether existing patents could restrict commercialization of products falling within this patent’s scope.
-
Potential Infringement Risks: Competitors might challenge or design around claims, influencing strategic patent drafting and R&D.
Patent Landscape Distribution
-
The earliest filings in this space date back several years, with subsequent filings refining knowledge.
-
The geographical spread indicates targeted markets (e.g., US, EU, China), influencing patent enforcement strategies.
Implications for Stakeholders
-
R&D Strategy: This patent informs resource allocation by highlighting protected chemical classes or therapeutic areas.
-
Licensing & Partnerships: Well-defined scope offers opportunities for licensing or collaborations, especially if the patent covers promising drug candidates.
-
Market Entry & Competition: Broad claims can act as barriers, requiring competitors to develop around the patent or invalidate invalid claims.
-
Legal Challenges: Given the typical robustness of such patents, patent challenges (inter partes review, oppositions) depend on prior art's strength and claims' clarity.
Conclusion
WO2012142504 embodies a strategically significant patent application within the pharmaceutical patent landscape. Its scope, grounded in well-crafted claims, hinges on the specific chemical modifications or use methods claimed, conferring potential market exclusivity. An understanding of its landscape—including prior art, competing patents, and legal robustness—is essential for effective R&D planning, licensing negotiations, and market positioning.
Key Takeaways
-
The scope is primarily defined by broad chemical and use claims, aiming to encompass a significant segment of therapeutically relevant derivatives.
-
Effective claim drafting balances breadth and specificity to withstand legal scrutiny and competitive challenges.
-
The patent landscape is dense with prior art, necessitating detailed freedom-to-operate and invalidity assessments.
-
Strategic patent positioning can secure competitive advantage, enabling licensing revenues or blockades.
-
Continuous monitoring of patent publications and legal statuses remains vital for risk mitigation and opportunity identification.
FAQs
1. What is the main innovation claimed by WO2012142504?
While the full claims are necessary for precise interpretation, the patent likely claims novel chemical compounds with therapeutic applications, along with methods of use or specific formulations addressing unmet medical needs.
2. How does this patent fit within the current patent landscape?
It probably overlaps with existing patents on similar chemical classes or therapeutic methods, necessitating detailed landscape and invalidity analyses before commercial exploitation.
3. Can competitors develop similar drugs around this patent?
Potentially, if they can engineer analogs outside the claim scope or challenge the patent’s validity based on prior art, though broad claims may pose substantial barriers.
4. What strategies can patent holders employ to defend this patent?
They can pursue patent term extensions, filing follow-up applications for new uses or formulations, and engaging in litigation or licensing to enforce rights.
5. How important is this patent for drug commercialization?
If it covers core compounds or methods of treatment, it can be a cornerstone patent, significantly impacting market access, partnerships, and revenue streams.
References
[1] WIPO Patent Application WO2012142504, published September 2012.
